Literature DB >> 11158514

Subcellular localization of bilirubin in rat brain after in vivo i.v. administration of [3H]bilirubin.

T Hansen1, S Tommarello, J Allen.   

Abstract

Bilirubin appears to be toxic in vitro to several cellular functions localized to different subcellular compartments. It would therefore be useful to know what concentrations of bilirubin might be found in cell organelles in vivo. Rats were anesthetized and allocated to one of three groups: control, hypercarbia, and hyperosmolality. Each rat received a 5-min bolus dose of bilirubin 50 mg/kg i.v. (containing approximately 200 microCi [(3)H]bilirubin). Rats were killed 10 or 30 min after the start of the bilirubin infusion. Each brain was homogenized, and subcellular fractions were isolated by high-speed gradient centrifugation in sucrose media. The gradients were separated into aliquots of 2 mL, and the protein content was determined in each aliquot. Radioactivity was determined by scintillation counting, and the content of bilirubin per milligram of protein was calculated. Statistical comparisons were performed with Kruskal-Wallis nonparametric ANOVA. There were highly significant differences in bilirubin content per milligram of protein among subcellular compartments in all groups and at both time points. In all groups there were relatively high concentrations of bilirubin in the myelin fraction, an interesting observation in light of the theory that membranes are the primary target of bilirubin toxicity. The very high concentration of bilirubin relative to protein in cytoplasm, ribosomes, and mitochondria in the hyperosmolar group are also notable in light of data from hyperbilirubinemic animals in which changes in electrophysiology or energy metabolism only appeared after hyperosmolar opening of the blood-brain barrier. The present data may be useful in planning in vitro studies of bilirubin toxicity in cell organelles.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158514     DOI: 10.1203/00006450-200102000-00012

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  11 in total

Review 1.  Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns.

Authors:  Jon F Watchko
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 2.  Glucose-6-Phosphate Dehydrogenase Deficiency and the Need for a Novel Treatment to Prevent Kernicterus.

Authors:  Anna D Cunningham; Sunhee Hwang; Daria Mochly-Rosen
Journal:  Clin Perinatol       Date:  2016-02-28       Impact factor: 3.430

3.  ER stress, mitochondrial dysfunction and calpain/JNK activation are involved in oligodendrocyte precursor cell death by unconjugated bilirubin.

Authors:  Andreia Barateiro; Ana Rita Vaz; Sandra Leitão Silva; Adelaide Fernandes; Dora Brites
Journal:  Neuromolecular Med       Date:  2012-06-17       Impact factor: 3.843

4.  Endocytosis in rat cultured astrocytes is inhibited by unconjugated bilirubin.

Authors:  R F Silva; L M Mata; S Gulbenkian; D Brites
Journal:  Neurochem Res       Date:  2001-07       Impact factor: 3.996

5.  Hyperbilirubinemia diminishes respiratory drive in a rat pup model.

Authors:  Oded Mesner; Martha J Miller; Sabine C Iben; K C Prabha; Catherine A Mayer; Musa A Haxhiu; Richard J Martin
Journal:  Pediatr Res       Date:  2008-09       Impact factor: 3.756

Review 6.  Cerebroprotective functions of HO-2.

Authors:  Helena Parfenova; Charles W Leffler
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

7.  Unconjugated bilirubin restricts oligodendrocyte differentiation and axonal myelination.

Authors:  Andreia Barateiro; Veronique E Miron; Sofia D Santos; João B Relvas; Adelaide Fernandes; Charles Ffrench-Constant; Dora Brites
Journal:  Mol Neurobiol       Date:  2012-10-21       Impact factor: 5.590

8.  The evolving landscape of neurotoxicity by unconjugated bilirubin: role of glial cells and inflammation.

Authors:  Dora Brites
Journal:  Front Pharmacol       Date:  2012-05-29       Impact factor: 5.810

9.  Hydrophilic bile acids protect human blood-brain barrier endothelial cells from disruption by unconjugated bilirubin: an in vitro study.

Authors:  Inês Palmela; Leonor Correia; Rui F M Silva; Hiroyuki Sasaki; Kwang S Kim; Dora Brites; Maria A Brito
Journal:  Front Neurosci       Date:  2015-03-13       Impact factor: 4.677

10.  Characterization of organic anion transporting polypeptide 1b2 knockout rats generated by CRISPR/Cas9: a novel model for drug transport and hyperbilirubinemia disease.

Authors:  Xinrun Ma; Xuyang Shang; Xuan Qin; Jian Lu; Mingyao Liu; Xin Wang
Journal:  Acta Pharm Sin B       Date:  2019-11-14       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.